This report summarises the key issues impacting prices across a range of categories in the Bio/Pharma industry in April 2024: Breakdown by category: Biologics contract manufacturing Although the global biologics contract development and manufacturing (CDMO) market is poised to register
Prices of pharma R&D and clinical trials are expected to increase due to a tight labour market with an ongoing shortage of qualified and experienced researchers. In addition, prices for Non Human Primates (NHPs) are currently 10x pre-COVID-19 levels.
Your guide to choose the right Cell and Gene Therapy CDMOs for your company
Ophthalmic APIs are small-volume products with high purity and stringent microbiology requirements. Watch the video, sponsored by C2 Pharma
The diabetes and obesity market is expanding rapidly, with GLP-1 agonists a key medication that is proven to lower blood sugar levels, they also suppress appetite and reduce calorie intake. J.P. Morgan Research forecasts that the GLP-1 market will exceed
Prices of pharma R&D and clinical trials are expected to increase due to a tight labour market with an ongoing shortage of qualified and experienced researchers. In addition, prices for Non Human Primates (NHPs) are currently 10x pre-COVID-19 levels.
Your guide to choosing the right partner for Pharmaceutical Method Development and Validation.
Contract Development and Manufacturing Organisations (CDMOs) have grown to become critical to the pharma ecosystem. Here’s what you need to know.
Tech Transfers are critical factor in these partnerships to be successful in developing, manufacturing and managing risk associated with moving manufacturing between sites.
This report summarises the likely impact of the Israel-Hamas war and other macros events across a range of categories, as of October 2023. The Israel–Hamas war poses a major geopolitical risk for oil markets, where a further escalation can lead
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
